Company intelligence / Profile preview

Polpharma

Starogard Gdański, Polandpolpharma.pl ↗

Ownership: Private
Employees: ~5600
Development stage: Commercial

Overview

Polpharma leads the Polish pharmaceutical market with over EUR €1.1 billion in annual revenue and produces more than 400 million medicine packages per year. It has extensive experience in generics and APIs with recent expansion into high-potency APIs for oncology and rare diseases. Its biologic division focuses on biosimilars but no specific clinical results are publicly highlighted.

Therapeutic areas: OncologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecules (generics and APIs)Biologics/biosimilarsHighly potent active pharmaceutical ingredients (HP API)
Industry: Biotech

Drug pipeline

1 asset

timonacic

Preclinical

Partnerships

Outlicensing/distribution partners active in over forty countries globally

Beyond the preview

Go deeper on Polpharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polpharma.

Explore the full profile